Skip to Main Content

Paper Details

Does KRAS testing in metastatic colorectal cancer impact overall survival? A comparative effectiveness study in a population-based sample.
PLoS One
5
2014
CRC, EGFR, Epidermal growth factor receptor, KRAS, PATIENTS, metastatic CRC, metastatic colorectal cancer, patients
Author NameAffiliation
Heather Spencer FeigelsonInstitute for Health Research, Kaiser Permanente Colorado
Pamala A PawloskiHealthPartners Institute for Education and Research
Carolyn Sue RichardsOregon Health & Science University
Tia L KauffmanThe Center for Health Research Kaiser Permanente Northwest
Catherine A McCartyEssentia Institute of Rural Health
Robert L DavisUniversity of Tennessee Health Sciences Center
Lawrence H KushiKaiser Permanente Northern California
Katrina A B GoddardThe Center for Health Research Kaiser Permanente Northwest
  • 1 - 8

Datasets